What is Myriad Genetics's shares (basic)?

Myriad Genetics (MYGN) reported shares (basic) of 93.7M in Q1 2026.

How has Myriad Genetics's shares (basic) changed year-over-year?

Myriad Genetics's shares (basic) increased by 2.5% year-over-year, from 91.4M to 93.7M.

What is the long-term trend for Myriad Genetics's shares (basic)?

Over 4 years (2021 to 2025), Myriad Genetics's shares (basic) has grown at a 4.5% compound annual growth rate (CAGR), from 310M to 369.6M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Myriad Genetics MYGN Shares (Basic)

Shares (Basic) at other companies

NeoGenomicsNEO

129.2M+1.4%

VeracyteVCYT

79.5M+1.9%

Guardant HealthGH

131.3M+6.0%

Natera, Inc.NTRA

141.5M+5.0%

Fulgent Genetics, Inc.FLGT

30.9M+0.2%

Quest DiagnosticsDGX

——

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's shares (basic)?: Myriad Genetics (MYGN) reported shares (basic) of 93.7M in Q1 2026.
How has Myriad Genetics's shares (basic) changed year-over-year?: Myriad Genetics's shares (basic) increased by 2.5% year-over-year, from 91.4M to 93.7M.
What is the long-term trend for Myriad Genetics's shares (basic)?: Over 4 years (2021 to 2025), Myriad Genetics's shares (basic) has grown at a 4.5% compound annual growth rate (CAGR), from 310M to 369.6M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.